Brilliant Violet 510™ anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30F11_BV510_CD45_Antibody_FC_083112
C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
  • 30F11_BV510_CD45_Antibody_FC_083112
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) Brilliant Violet 510™.
Compare all formats See Brilliant Violet 510™ spectral data
Cat # Size Price Quantity Check Availability Save
103137 125 µL 146€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103138 50 µg 194€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 510™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the µg size, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. For immunofluorescent staining using the µl size, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  2. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  3. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  4. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  5. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  6. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  7. Benitez AA, et al. 2020. Commun Biol. 0.371527778. PubMed
  8. Gawish R, et al. 2022. Elife. 11:. PubMed
  9. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  10. Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
  11. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  12. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  13. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  14. Dong L, et al. 2021. Cancer Cell. . PubMed
  15. Pan XX, et al. 2021. Front Cell Dev Biol. 637424:9. PubMed
  16. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  17. Poli V, et al. 2021. iScience. 24:103256. PubMed
  18. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  19. Alam J, et al. 2022. Mucosal Immunol. 15:620. PubMed
  20. Scott CL et al. 2018. Immunity. 49(2):312-325 . PubMed
  21. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  22. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  23. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  24. Upadhyaya P, et al. 2021. J Immunother Cancer. 9:00. PubMed
  25. Wang L, et al. 2022. Cancer Res Commun. 2:518. PubMed
  26. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  27. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  28. Wang Y, et al. 2021. Cancer Cell. :. PubMed
  29. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  30. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  31. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  32. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  33. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  34. Yoshihara E, et al. 2020. Nature. 606:586. PubMed
  35. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  36. LaMarche NM, et al. 2020. Cell Metabolism. 32(2):243-258.e6. PubMed
  37. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  38. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  39. Xu Y, et al. 2021. Stem Cell Res Ther. 12:112. PubMed
  40. Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
  41. Thanabalasuriar A et al. 2019. Cell Host Microbe. 25(4):526-536 . PubMed
  42. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  43. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  44. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  45. Taguchi K, et al. 2015. J Urol. . PubMed
  46. Wang H, et al. 2021. Malar J. 20:249. PubMed
  47. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  48. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  49. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  50. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  51. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  52. Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
  53. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  54. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  55. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  56. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  57. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  58. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  59. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  60. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  61. Dang MT, et al. 2021. Cell Reports. 34(13):108917. PubMed
  62. Silver J, et al. 2020. Methods Mol Biol. 2121:115. PubMed
  63. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  64. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  65. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  66. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  67. Lima-Junior DS, et al. 2021. Cell. . PubMed
  68. Alam J, et al. 2021. Front Immunol. 12:701415. PubMed
  69. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  70. Kalavska K, et al. 2021. Int J Mol Sci. 22:. PubMed
  71. Jacobson A et al. 2018. Cell host & microbe. 24(2):296-307 . PubMed
  72. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  73. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  74. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  75. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  76. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  77. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  78. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  79. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  80. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  81. Ayari A, et al. 2020. Commun Biol. 3:237. PubMed
  82. Dang MT, et al. 2021. STAR Protoc. 2:100957. PubMed
  83. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  84. Xiao Y, et al. 2018. Int Immunol. 30:457. PubMed
  85. Louka E, et al. 2021. Journal of Experimental Medicine. 218(2):. PubMed
  86. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  87. Kalavska K, et al. 2022. Front Oncol. 12:858797. PubMed
  88. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  89. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  90. Jordan S, et al. 2020. Cell. 178(5):1102-1114.e17.. PubMed
  91. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  92. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  93. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  94. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  95. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  96. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  97. Seki N, et al. 2022. iScience. 25:104838. PubMed
  98. Chen H, et al. 2022. Mol Ther Methods Clin Dev. 27:431. PubMed
  99. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  100. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  101. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  102. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  103. Silva DA, et al. 2019. Nature. 565:186. PubMed
  104. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  105. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  106. Zamarin D, et al. 2020. Clin Cancer Res. 26:4531. PubMed
  107. Domanska D, et al. 2022. J Exp Med. 219:. PubMed
  108. Liu J, et al. 2022. Nat Commun. 13:4308. PubMed
  109. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  110. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  111. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  112. Xia L, et al. 2021. Cell Chemical Biology. 28(5):610-624.e5. PubMed
  113. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  114. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  115. Smith LK, et al. 2021. Elife. 10:. PubMed
  116. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  117. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  118. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  119. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  120. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  121. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  122. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  123. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  124. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  125. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  126. Figueiredo CA, et al. 2022. J Neuroinflammation. 19:17. PubMed
  127. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  128. Sfakianos JP, et al. 2020. Nat Commun. 2.222222222. PubMed
  129. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  130. Weinstock A, et al. 2019. Immunometabolism. 1. PubMed
RRID
AB_2561392 (BioLegend Cat. No. 103137)
AB_2563061 (BioLegend Cat. No. 103138)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC, IHC-F, CyTOF®, IP, CMCD, IHC, WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC, SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC, ICC, IHC, 3D IHC, SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC, SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F, FC, 3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC, SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC, CyTOF®, IP, CMCD, IHC, WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD45

  • Biotin anti-mouse CD45

  • FITC anti-mouse CD45

  • PE anti-mouse CD45

  • PE/Cyanine5 anti-mouse CD45

  • Purified anti-mouse CD45

  • PE/Cyanine7 anti-mouse CD45

  • APC/Cyanine7 anti-mouse CD45

  • Alexa Fluor® 488 anti-mouse CD45

  • Alexa Fluor® 647 anti-mouse CD45

  • Pacific Blue™ anti-mouse CD45

  • Alexa Fluor® 700 anti-mouse CD45

  • PerCP/Cyanine5.5 anti-mouse CD45

  • PerCP anti-mouse CD45

  • Alexa Fluor® 594 anti-mouse CD45

  • Brilliant Violet 421™ anti-mouse CD45

  • Brilliant Violet 570™ anti-mouse CD45

  • Brilliant Violet 510™ anti-mouse CD45

  • Brilliant Violet 605™ anti-mouse CD45

  • Purified anti-mouse CD45 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45

  • Brilliant Violet 711™ anti-mouse CD45

  • Brilliant Violet 785™ anti-mouse CD45

  • Brilliant Violet 650™ anti-mouse CD45

  • APC/Fire™ 750 anti-mouse CD45

  • Brilliant Violet 750™ anti-mouse CD45

  • TotalSeq™-A0096 anti-mouse CD45

  • TotalSeq™-B0096 anti-mouse CD45

  • Ultra-LEAF™ Purified anti-mouse CD45

  • Spark Blue™ 550 anti-mouse CD45

  • Spark NIR™ 685 anti-mouse CD45

  • TotalSeq™-C0096 anti-mouse CD45

  • Spark YG™ 570 anti-mouse CD45

  • PE/Fire™ 640 anti-mouse CD45

  • APC/Fire™ 810 anti-mouse CD45

  • PE/Fire™ 700 anti-mouse CD45

  • Spark Violet™ 538 anti-mouse CD45

  • Spark YG™ 593 anti-mouse CD45

  • Spark Blue™ 574 anti-mouse CD45 Antibody

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account